100% Zufriedenheitsgarantie Sofort verfügbar nach Zahlung Sowohl online als auch als PDF Du bist an nichts gebunden
logo-home
Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+. 17,79 €   In den Einkaufswagen

Prüfung

Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.

 6 mal angesehen  0 mal verkauft
  • Kurs
  • Pharmacology And The Nursing Process 9th Editio
  • Hochschule
  • Pharmacology And The Nursing Process 9th Editio
  • Book

Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.Test Bank for Pharmacology an...

[ Mehr anzeigen ]

vorschau 4 aus 582   Seiten

  • 2. oktober 2024
  • 582
  • 2024/2025
  • Prüfung
  • Fragen & Antworten
  • Pharmacology And The Nursing Process 9th Editio
  • Pharmacology And The Nursing Process 9th Editio
avatar-seller
,Chapter 01: The Nursing Process and Drug Therapy......................................................................................... 7
I;, I;, I;, I;, I;, I;, I;,




Chapter 02: Pharmacologic Principles ............................................................................................................. 14
I;, I;, I;,




Chapter 03: Lifespan Considerations ............................................................................................................... 24
I;, I;, I;,




Chapter 04: Cultural, Legal, and Ethical Considerations................................................................................... 35
I;, I;, I;, I;, I;, I;,




Chapter 05: Medication Errors: Preventing and Responding .......................................................................... 45
I;, I;, I;, I;, I;, I;,




Chapter 06: Patient Education and Drug Therapy ........................................................................................... 50
I;, I;, I;, I;, I;, I;,




Chapter 07: Over-the-Counter Drugs and Herbal and DietarySupplements ................................................ 58
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 08: Gene Therapy and Pharmacogenomics ....................................................................................... 64
I;, I;, I;, I;, I;,




Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 68
I;, I;, I;, I;, I;, I;,




Chapter 10: Analgesic Drugs ........................................................................................................................... 85
I;, I;, I;,




Chapter 11: General and Local Anesthetics .................................................................................................... 97
I;, I;, I;, I;, I;,




Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................... 105
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 13: Central Nervous System Stimulants and Related Drugs ............................................................. 115
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 14: Antiepileptic Drugs .................................................................................................................... 121
I;, I;, I;,




Chapter 15: Antiparkinson Drugs .................................................................................................................. 132
I;, I;, I;,




Chapter 16: Psychotherapeutic Drugs ........................................................................................................... 142
I;, I;, I;,




Chapter 17: Substance Use Disorder............................................................................................................. 156
I;, I;, I;, I;,




Chapter 18: Adrenergic Drugs....................................................................................................................... 162
I;, I;, I;,




Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................... 10
I;, I;, I;,




Chapter 20: Cholinergic Drugs....................................................................................................................... 116
I;, I;, I;,




Chapter 21: Cholinergic-Blocking Drugs .......................................................................................................... 11
I;, I;, I;,




Chapter 22: Antihypertensive Drugs ............................................................................................................. 126
I;, I;, I;,




Chapter 23: Antianginal Drugs ........................................................................................................................ 11
I;, I;, I;,




Chapter 24: Heart Failure Drugs.................................................................................................................... 129
I;, I;, I;, I;,




Chapter 25: Antidysrhythmic Drugs .............................................................................................................. 142
I;, I;, I;,




Chapter 26: Coagulation Modifier Drugs ....................................................................................................... 154
I;, I;, I;, I;,




Chapter 27: Antilipemic Drugs ...................................................................................................................... 166
I;, I;, I;,




Chapter 28: Diuretic Drugs ........................................................................................................................... 175
I;, I;, I;,




Chapter 29: Fluids and Electrolytes ............................................................................................................... 187
I;, I;, I;, I;,




Chapter 30: Pituitary Drugs ........................................................................................................................... 197
I;, I;, I;,




Chapter 31: Thyroid and Antithyroid Drugs .................................................................................................. 202
I;, I;, I;, I;, I;,




Chapter 32: Antidiabetic Drugs ..................................................................................................................... 210
I;, I;, I;,




Chapter 33: Adrenal Drugs ........................................................................................................................... 229
I;, I;, I;,

,Chapter 34: Women’s Health Drugs ............................................................................................................. 236
I;, I;, I;, I;,




Chapter 35: Men’s Health Drugs ................................................................................................................... 249
I;, I;, I;, I;,




Chapter 36: Antihistamines, Decongestants, Antitussives, andExpectorants ............................................ 259
I;, I;, I;, I;, I;, I;,




Chapter 37: Respiratory Drugs ...................................................................................................................... 270
I;, I;, I;,




Chapter 38: Antibiotics Part 1 ...................................................................................................................... 280
I;, I;, I;, I;,




Chapter 39: Antibiotics Part 2....................................................................................................................... 294
I;, I;, I;, I;,




Chapter 40: Antiviral Drugs ........................................................................................................................... 303
I;, I;, I;,




Chapter 41: Antitubercular Drugs ................................................................................................................. 313
I;, I;, I;,




Chapter 42: Antifungal Drugs ....................................................................................................................... 321
I;, I;, I;,




Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ................................................................... 24
I;, I;, I;, I;, I;, I;,




Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs ........................... 270
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugsand Miscellaneous Drugs ........... 283
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs............................................................ 292
I;, I;, I;, I;, I;, I;,




Chapter 48: Immunosuppressant Drugs........................................................................................................ 301
I;, I;, I;,




Chapter 49: Immunizing Drugs ..................................................................................................................... 311
I;, I;, I;,




Chapter 50: Acid-Controlling Drugs............................................................................................................... 320
I;, I;, I;,




Chapter 51: Bowel Disorder Drugs ................................................................................................................ 333
I;, I;, I;, I;,




Chapter 52: Antiemetic and Antinausea Drugs ............................................................................................. 348
I;, I;, I;, I;, I;,




Chapter 53: Vitamins and Minerals ............................................................................................................... 358
I;, I;, I;, I;,




Chapter 54: Anemia Drugs ............................................................................................................................ 369
I;, I;, I;,




Chapter 55: Nutritional Supplements ............................................................................................................ 382
I;, I;, I;,




Chapter 56: Dermatologic Drugs................................................................................................................... 389
I;, I;, I;,




Chapter 57: Ophthalmic Drugs ...................................................................................................................... 402
I;, I;, I;,




Chapter 58: Otic Drugs .................................................................................................................................. 410
I;, I;, I;,

, Chapter 01: The Nursing Process and Drug Therapy I;, I;, I;, I;, I;, I;, I;,




MULTIPLE CHOICE I;,




1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



newlydiagnosed with type 2 diabetes. Which statement reflects the correct format for a
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



nursing diagnosis?
I;, I;,



a. Anxiety
b. Anxietyrelated to new drug therapy I;, I;, I;, I;, I;,



c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



statementssuch as ―I‘m upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



d. Anxietyrelated to new drug therapy, as evidenced by statements such as ―I‘m
I;, I;, I;, I;, I;, I;, I;, I; , I;, I;, I;, I;,



upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;,




ANS: D I;,



Formulation of nursing diagnoses is usually a three-step process. ―Anxiety‖ is missing the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



―related to‖ and ―as evidenced by‖ portions of defining characteristics. ―Anxiety related to new
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



drug therapy‖ is missing the ―as evidenced by‖ portion of defining characteristics. The
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



statementbeginning ―Anxiety related to anxious feelings‖ is incorrect because the ―related to‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



section is simply a restatement of the problem ―anxiety,‖ not a separate factor related to the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



response.
I;,




DIF: COGNITIVE LEVEL: Understanding I;, I;,



(Comprehension)TOP: NURSING PROCESS: Nursing
I;, I;, I ; , I;, I;,



Diagnosis
I;,



MSC: NCLEX: Safe and Effective Care Environment: Management of Care
I ; , I;, I;, I;, I;, I;, I;, I;, I;,




2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



andgave the medication 2 hours after the scheduled dose was due. What type of problem does
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



this represent?
I;, I;,



a. ―Right time‖ I;,



b. ―Right dose‖ I;,



c. ―Right route‖ I;,



d. ―Right medication‖ I;,




ANS: A I;,



―Right time‖ is correct because the medication was given more than 30 minutes after the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



medication administration is scheduled. ―Route‖ is incorrect because the route is not affected.
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



―Medication‖ is incorrect because the medication ordered will not change. I;, I;, I;, I;, I;, I; , I;, I;, I;,




DIF: COGNITIVE LEVEL: Applying I;, I;,



(Application)TOP: NURSING PROCESS:
I;, I;, I ; , I;,



Implementation
I;,



MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
I ; , I;, I;, I;, I;, I;, I;, I;, I;, I;,




3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



I;, doseand documenting the patient‘s therapeutic response to the medication. Which phase of
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,

Alle Vorteile der Zusammenfassungen von Stuvia auf einen Blick:

Garantiert gute Qualität durch Reviews

Garantiert gute Qualität durch Reviews

Stuvia Verkäufer haben mehr als 700.000 Zusammenfassungen beurteilt. Deshalb weißt du dass du das beste Dokument kaufst.

Schnell und einfach kaufen

Schnell und einfach kaufen

Man bezahlt schnell und einfach mit iDeal, Kreditkarte oder Stuvia-Kredit für die Zusammenfassungen. Man braucht keine Mitgliedschaft.

Konzentration auf den Kern der Sache

Konzentration auf den Kern der Sache

Deine Mitstudenten schreiben die Zusammenfassungen. Deshalb enthalten die Zusammenfassungen immer aktuelle, zuverlässige und up-to-date Informationen. Damit kommst du schnell zum Kern der Sache.

Häufig gestellte Fragen

Was bekomme ich, wenn ich dieses Dokument kaufe?

Du erhältst eine PDF-Datei, die sofort nach dem Kauf verfügbar ist. Das gekaufte Dokument ist jederzeit, überall und unbegrenzt über dein Profil zugänglich.

Zufriedenheitsgarantie: Wie funktioniert das?

Unsere Zufriedenheitsgarantie sorgt dafür, dass du immer eine Lernunterlage findest, die zu dir passt. Du füllst ein Formular aus und unser Kundendienstteam kümmert sich um den Rest.

Wem kaufe ich diese Zusammenfassung ab?

Stuvia ist ein Marktplatz, du kaufst dieses Dokument also nicht von uns, sondern vom Verkäufer Wisdoms. Stuvia erleichtert die Zahlung an den Verkäufer.

Werde ich an ein Abonnement gebunden sein?

Nein, du kaufst diese Zusammenfassung nur für 17,79 €. Du bist nach deinem Kauf an nichts gebunden.

Kann man Stuvia trauen?

4.6 Sterne auf Google & Trustpilot (+1000 reviews)

45.681 Zusammenfassungen wurden in den letzten 30 Tagen verkauft

Gegründet 2010, seit 14 Jahren die erste Adresse für Zusammenfassungen

Starte mit dem Verkauf
17,79 €
  • (0)
  Kaufen